Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Objectives To assess the beneficial and harmful effects of duloxetine versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder.Design Systematic review with meta-analysis and trial sequential analysis of randomised trials.Data sources Cochrane Central Register of...
Saved in:
Main Authors: | Christian Gluud, Marija Barbateskovic, Joanna Moncrieff, Faiza Siddiqui, Janus C Jakobsen, Mathias Maagaard, Sophie Juul, Johanne Juul Petersen, Caroline Barkholt Kamp, Mark Abie Horowitz, Kiran Kumar Katakam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e082853.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
by: Caroline Barkholt Kamp, et al.
Published: (2025-01-01) -
Aluminium adjuvants versus placebo or no intervention in vaccine randomised clinical trials: a systematic review with meta-analysis and Trial Sequential Analysis
by: Christian Gluud, et al.
Published: (2022-06-01) -
Randomization and placebo effects in clinical trials of major depressive disorder
by: James A. Rogers, et al.
Published: (2025-02-01) -
Should the Food and Drug Administration Limit Placebo-Controlled Trials?
by: Max Goodman, et al.
Published: (2022-07-01) -
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
by: Claus Thorn Ekstrøm, et al.
Published: (2022-10-01)